Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Liabilities (2021 - 2025)

Lucid Diagnostics' Total Liabilities history spans 5 years, with the latest figure at $29.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 16.53% year-over-year to $29.5 million; the TTM value through Dec 2025 reached $29.5 million, up 16.53%, while the annual FY2025 figure was $29.5 million, 16.53% up from the prior year.
  • Total Liabilities reached $29.5 million in Q4 2025 per LUCD's latest filing, up from $27.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $38.2 million in Q1 2025 to a low of $4.3 million in Q4 2021.
  • Average Total Liabilities over 5 years is $21.5 million, with a median of $22.2 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: tumbled 60.47% in 2022, then surged 212.63% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $4.3 million in 2021, then surged by 122.11% to $9.5 million in 2022, then soared by 212.63% to $29.6 million in 2023, then fell by 14.39% to $25.3 million in 2024, then rose by 16.53% to $29.5 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Total Liabilities are $29.5 million (Q4 2025), $27.4 million (Q3 2025), and $30.8 million (Q2 2025).